EGF and neoplasm: While MenaINV is known to increase EGF-elicited phosphorylation of cortactin at tyrosine 42143, whether this increase in cortactin tyrosine 421 phosphorylation occurs within specific subcellular compartments, and how this contributes to tumor cell phenotype, have not been determined.